This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) inched 0.35% higher to $146.91 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.41% to 3,856.10 and Dow Jones Industrial Average falling 0.24% to 32,653.20. The stock's rise snapped a two-day losing streak. AbbVie Inc. closed $29.00 short of its 52-week high ($175.91), which the company reached on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Pfizer Inc. (PFE) rose 3.14% to $48.01, Eli Lilly & Co. (LLY) fell 2.63% to $352.58, and AstraZeneca PLC ADR (AZN.LN) rose 1.77% to $59.85. Trading volume (6.4 M) eclipsed its 50-day average volume of 5.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 1, 2022.
(END) Dow Jones Newswires
November 01, 2022 16:33 ET (20:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.